产业链观察03-15 00:14
#药闻简讯# 美国FDA已批准$Mirum制药(MIRM)$ LIVMARLI(maralixibat)口服溶液用于治疗5岁及以上进行性家族性肝内胆汁淤积症(PFIC)患者的胆汁淤积性瘙痒。查看全文
SeekingBiotech2023-12-19 07:13
MIRM Announces Data from EMBARK Phase 2b Study for Biliary Atresia.
- Study did not meet primary or secondary endpoints
$Mirum制药(MIRM)$$北海康成-B(01228)$查看全文
产业链观察2023-07-17 21:29
#药闻简讯# $Mirum制药(MIRM)$ 达成协议从Travere Therapeutics收购治疗罕见肝病的胆汁酸产品组合
Mirum 将收购 Travere 与 Cholbam® 和 Chenodal® 相关的所有权利和资产
Travere将获得高达4.45亿美元的预付款,其中2.1亿美元为预付款,高达2.35亿美元为基于销售额...查看全文
牛唐2023-07-18 22:02
医药板块速评(2022.07.17)
1、$Mirum制药(MIRM)融资买入资产,如何看待后续走势?
2、$Apellis制药(APLS)暴跌,是否有抄底机会?
3、$CrowdStrike Holdings(CRWD)$ 、$BridgeBio Pharma(BBIO)、$Palantir(PLTR)$ 、$PayPal(PYPL)$ 、$Snap Inc.(SNAP)等期权异动,后续走势如何看?查看全文
SeekingBiotech2023-04-05 22:26
MIRM Submits for European Approval of LIVMARLI in Progressive Familial Intrahepatic Cholestasis$Mirum制药(MIRM)$
家族性肝内胆汁淤积查看全文
牛唐2022-11-30 17:33
医药板块速评(2022.11.29)
1、$Horizon Therapeutics(HZNP)$ 多家大药企在谈并购,是否有加仓机会?
2、$Mirum制药(MIRM)管线暂停,是否有抄底机会?
3、$爱奇艺(IQ)$ 、$阿里巴巴-SW(09988)$ 、$苹果(AAPL)期权异动,后续走势如何看?查看全文
Mirum(MIRM)03-26 05:45
$Mirum制药(MIRM)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001415889-24-009046 Size: 5 KB 网页链接查看全文
$Mirum制药(MIRM)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001415889-24-009280 Size: 4 KB 网页链接
$Mirum制药(MIRM)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001415889-24-009046 Size: 5 KB 网页链接
$Mirum制药(MIRM)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001415889-24-008320 Size: 5 KB 网页链接
$Mirum制药(MIRM)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001415889-24-008322 Size: 4 KB 网页链接
$Mirum制药(MIRM)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001415889-24-008311 Size: 4 KB 网页链接
$Mirum制药(MIRM)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001415889-24-008313 Size: 5 KB 网页链接
$Mirum制药(MIRM)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001415889-24-008316 Size: 6 KB 网页链接
$Mirum制药(MIRM)$ S-8 Securities to be offered to employees in employee benefit plans Accession Number: 0001193125-24-069301 Act: 33 Size: 81 KB 网页链接
$Mirum制药(MIRM)$ 10-K Annual report [Section 13 and 15(d), not S-K Item 405] Accession Number: 0000950170-24-032289 Act: 34 Size: 15 MB 网页链接
$Mirum制药(MIRM)$ NT 10-K Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 Accession Number: 0001193125-24-050798 Act: 34 Size: 26 KB 网页链接